Delivery Order SPE2DB24D1205-SPE2DB25FCRHS

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCRHS
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a firm fixed-price delivery order valued at $10,134.52. The award provides for the delivery of 4,566,307,182 units of the drug JANUVIA 100 MG TABLET 1000S. The contract has a completion date of November 4, 2024 and was awarded on November 1, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that is registered in the System for Award Management (SAM.gov) through June 11, 2025. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This delivery order award is not designated with a set-aside requirement, indicating open competition. The contract supports the DLA's mission of providing medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 1/31/25, 9:02 AM